Sumitomo Pharma Co., Ltd.
SMDPY · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $24 | -$315 | -$97 | $41 |
| Dep. & Amort. | $26 | $38 | $41 | $38 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$19 | -$96 | $35 | -$34 |
| Other Non-Cash | -$14 | $131 | $33 | -$14 |
| Operating Cash Flow | $17 | -$242 | $12 | $31 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$8 | -$16 | -$13 | -$13 |
| Net Acquisitions | $1 | $9 | $30 | -$4 |
| Inv. Purchases | -$2 | -$5 | -$6 | -$26 |
| Inv. Sales/Matur. | $108 | $34 | $10 | $19 |
| Other Inv. Act. | -$0 | $10 | $31 | $5 |
| Investing Cash Flow | $100 | $33 | $52 | -$18 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$112 | $84 | $65 | -$5 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$0 | -$3 | -$11 | -$11 |
| Other Fin. Act. | $4 | -$3 | -$201 | -$5 |
| Financing Cash Flow | -$109 | $78 | -$147 | -$21 |
| Forex Effect | -$0 | $15 | $24 | $18 |
| Net Chg. in Cash | -$6 | -$114 | -$60 | $9 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $29 | $143 | $203 | $194 |
| End Cash | $23 | $29 | $143 | $203 |
| Free Cash Flow | $3 | -$258 | -$1 | $18 |